BridgeMD
New treatment option for Cigarette Smoking-Related Carcinoma
Official title Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
ClinicalTrials.gov ID: NCT05008848
What this study is testing
- What it's testing
- This phase III trial compares the effect of text-based cessation intervention to a manual in helping rural cancer patients who smoke, quit. Text-based scheduled gradual reduction may reduce the frequency of cigarette use to zero and may be effective in quitting smoking.
- Phase 3: a large, late-stage study
- Time commitment: about 8 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Have a cancer diagnosis within the past 10 years, and can currently be receiving curative treatment
- Not currently on hospice
- Currently smokes \>= 5 cigarettes daily
- Lives in a nonmetro/rural county (defined as having a Rural Urban Continuum Code [RUCC] code of 4-9)
- Patient interested in participating in a smoking cessation program, and not currently participating in a smoking cessation clinical trial
You likely can't join if
- Psychiatric illness which would prevent the patient from giving informed consent
- Patients with impaired decision-making capacity are not eligible for this study.
See the full eligibility criteria
- Have a cancer diagnosis within the past 10 years, and can currently be receiving curative treatment
- Not currently on hospice
- Currently smokes \>= 5 cigarettes daily
- Lives in a nonmetro/rural county (defined as having a Rural Urban Continuum Code [RUCC] code of 4-9)
- Patient interested in participating in a smoking cessation program, and not currently participating in a smoking cessation clinical trial
- Not currently using any smoking cessation pharmacotherapy (e.g. nicotine replacement therapy, bupropion or varenicline), or currently participating in any cessation program
- Patient has a cell phone or smart phone device with texting ability
- In order to complete the mandatory patient-completed measures, participants must be able to speak and read English
- Age \>= 18 years
- Participant must be willing to provide a urine sample.
- Psychiatric illness which would prevent the patient from giving informed consent
- Patients with impaired decision-making capacity are not eligible for this study.
The study team makes the final eligibility decision.
Where it's taking place
- Kingman, Arizona, United States
- Fort Smith, Arkansas, United States
- St. Helena, California, United States
- Greeley, Colorado, United States
- Loveland, Colorado, United States
- Braselton, Georgia, United States
- Gainesville, Georgia, United States
- Savannah, Georgia, United States
- Boise, Idaho, United States
- Caldwell, Idaho, United States
- Coeur d'Alene, Idaho, United States
- Nampa, Idaho, United States
- Post Falls, Idaho, United States
- Sandpoint, Idaho, United States
- Alton, Illinois, United States
- Aurora, Illinois, United States
- Bloomington, Illinois, United States
- Canton, Illinois, United States
- Carthage, Illinois, United States
- Centralia, Illinois, United States
+ 168 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 8 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kingman, Arizona, United States; Fort Smith, Arkansas, United States; St. Helena, California, United States; Greeley, Colorado, United States; Loveland, Colorado, United States; Braselton, Georgia, United States and 182 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.